Fabtech Technologies Limited
122.79
INR
-3.76
(-2.97%)
Fabtech Technologies Limited
NSE:FABTECH
(National Stock Exchange of India)
Recent
price
122.79
P/E
ratio
44.18
div
yld
- -
ROIC.AI
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.- Similar Companies
- Business
- Fabtech Technologies Limited is an India-based biopharmaceutical engineering and turnkey solutions provider that designs, engineers, manufactures, installs, and commissions end-to-end manufacturing facilities for the pharmaceutical, biotechnology, healthcare, and life sciences industries. The company operates through a fully integrated project lifecycle model spanning conceptual engineering, project management, cleanroom infrastructure, containment systems, process machinery, utility installations, and regulatory qualification. Its comprehensive product and service offerings comprise modular cleanroom systems, including modular wall and ceiling panels, flush doors, cleanroom view panels, dynamic and static pass boxes, and air showers; heating, ventilation, and air conditioning (HVAC) systems, encompassing air handling units, industrial ducting, HEPA filtration systems, dehumidification units, and automated building management systems; pharmaceutical process and packaging machinery, including high shear granulators, fluid bed dryers, tablet compression machines, automated tablet coaters, capsule filling equipment, and aseptic liquid injectable filling and sealing lines; containment and barrier isolation systems, featuring cytotoxic containment isolators, sterility test isolators, laminar air flow units, and sampling and dispensing booths; critical utility infrastructure, including purified water systems, water for injection generation plants, pure steam generators, and process piping; and specialized engineering consultancy services, covering basic and detailed design, facility master planning, technology transfer, computerized system validation, and regulatory compliance support aligned with US FDA, EU GMP, and WHO GMP standards. Headquartered in Mumbai, Maharashtra, India, and originally incorporated in 2018 before converting to a public limited company in 2024, Fabtech Technologies Limited serves clients across more than 60 countries in the Middle East, Africa, Asia-Pacific, Latin America, Europe, and the CIS region, utilizing advanced manufacturing facilities located in Umbergaon, Gujarat. In recent developments, the company completed its initial public offering on the National Stock Exchange of India and the Bombay Stock Exchange in October 2025, raising approximately 230.35 crore rupees to fund expansion and strategic acquisitions. Demonstrating strategic integration, Fabtech Technologies acquired a controlling 60.53 percent stake in Kelvin Air Conditioning & Ventilation Systems Private Limited across 2025 and 2026 to internalize specialized HVAC engineering capabilities, alongside acquiring a strategic stake in Aart Integrated Projects. Additionally, the company established an overseas manufacturing subsidiary in the United Arab Emirates to produce modular cleanroom partitions for regional markets, entered into a strategic green-engineering alliance with KP Group to develop renewable-powered cleanroom facilities, and secured multiple high-value international turnkey contracts across Africa, the Middle East, and Central Asia, including a major facility project for the Botswana Vaccine Institute.